Seneca Biopharma, Inc.
(NASDAQ : CUR)

( )
CUR PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 2.36%163.800.0%$1378.93m
AMGNAmgen, Inc. 0.45%250.751.3%$694.75m
NVAXNovavax, Inc. 2.18%205.7280.0%$583.54m
SNSSSunesis Pharmaceuticals, Inc. 0.00%7.880.7%$550.84m
ILMNIllumina, Inc. 0.00%398.073.5%$515.02m
GILDGilead Sciences, Inc. 0.46%65.601.0%$467.48m
REGNRegeneron Pharmaceuticals, Inc. 0.60%484.042.7%$434.23m
VRTXVertex Pharmaceuticals, Inc. 0.00%217.131.9%$373.76m
ALXNAlexion Pharmaceuticals, Inc. 0.00%155.292.0%$316.00m
BIIBBiogen, Inc. 0.00%265.791.7%$265.53m
BNTXBioNTech SE 1.61%134.730.0%$240.12m
EXASEXACT Sciences Corp. 0.00%127.1418.4%$192.79m
CRSPCRISPR Therapeutics AG 1.50%124.960.6%$179.57m
NBIXNeurocrine Biosciences, Inc. 0.00%95.054.9%$177.79m
TWSTTwist Bioscience Corp. -0.32%141.570.0%$150.49m

Company Profile

Seneca Biopharma, Inc. operates as a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel & proprietary chemical entity screening platform. The company was founded by I. Richard Garr, Karl Y. Johe, and Merrill Solomon in 1996 and is headquartered in Germantown, MD.